Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. ... 20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0867 | -9.87809046371 | 0.8777 | 0.929899 | 0.758 | 83220 | 0.81977876 | CS |
| 4 | -0.629 | -44.2957746479 | 1.42 | 1.5 | 0.758 | 621492 | 0.98543842 | CS |
| 12 | -1.349 | -63.0373831776 | 2.14 | 2.2 | 0.758 | 315049 | 1.23491906 | CS |
| 26 | -18.609 | -95.9226804124 | 19.4 | 20.663 | 0.758 | 337177 | 2.28072949 | CS |
| 52 | -18.609 | -95.9226804124 | 19.4 | 20.663 | 0.758 | 337177 | 2.28072949 | CS |
| 156 | -18.609 | -95.9226804124 | 19.4 | 20.663 | 0.758 | 337177 | 2.28072949 | CS |
| 260 | -18.609 | -95.9226804124 | 19.4 | 20.663 | 0.758 | 337177 | 2.28072949 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
